US Patent Issued to IMBRIA PHARMACEUTICALS on April 29 for "Methods of treating kidney conditions using modified forms of trimetazidine" (Massachusetts Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,428, issued on April 29, was assigned to IMBRIA PHARMACEUTICALS INC. (Boston).

"Methods of treating kidney conditions using modified forms of trimetazidine" was invented by Paul Chamberlin (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods of treating kidney conditions using compositions that contain modified forms of trimetazidine, such as CV-8972. Providing such compositions increases energy production in the kidney. Therefore, methods of the invention are useful for treating a variety of kidney conditions, such as acute kidney disease, chronic kidney disease, chronic kidney insufficiency, diabetic kidne...